Get the Stockscreener App
0.00
100.00%
-15.82
After Hours:
15.90
15.90
+
Eyenovia Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.
See More
Previous Close:
$15.82
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$11.76M
Revenue:
$31,800
Net Income/Loss:
$-37.83M
P/E Ratio:
0.00
EPS:
-0.71
Net Cash Flow:
$-30.64M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$124.80
Eyenovia Inc Stock (EYEN) Company Profile
Name
Eyenovia Inc
Sector
Industry
Phone
813-766-9539
Address
295 MADISON AVENUE,, NEW YORK, NY
Compare EYEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EYEN
Eyenovia Inc
|
0.00 | 11.76M | 31,800 | -37.83M | -30.64M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-01-21 | Initiated | Northland Capital | Outperform |
| Feb-03-20 | Downgrade | Oppenheimer | Outperform → Perform |
Eyenovia Inc Stock (EYEN) Latest News
Does Eyenovia Inc. stock pay reliable dividendsConsistently high returns - jammulinksnews.com
What drives Eyenovia Inc. stock priceUnprecedented profits - jammulinksnews.com
Is Eyenovia Inc. a good long term investmentFree Risk Assessment Services - jammulinksnews.com
What analysts say about Eyenovia Inc. stockFree Stock Market Return Analysis - Autocar Professional
Eyenovia Inc. Stock Analysis and ForecastTremendous return on equity - jammulinksnews.com
Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025 - The Manila Times
Hyperion DeFi shares rise 6.91% premarket after name and ticker change announcement. - AInvest
Hyperion DeFi shares rise 5.71% premarket after name and ticker change announcement. - AInvest
Eyenovia rebrands as Hyperion DeFi, Inc with new focus - Eyes On Eyecare
Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc. - VisionMonday.com
Hyperion DeFi stock soars after company rebrands from Eyenovia - Investing.com Australia
Hyperion DeFi stock soars after company rebrands from Eyenovia By Investing.com - Investing.com Nigeria
Eyenovia Announces Rebranding and Corporate Name Change to Hyper - GuruFocus
Eyenovia Inc Rebrands as Hyperion DeFi - Investing.com India
Eyenovia Inc Rebrands as Hyperion DeFi By Investing.com - Investing.com Australia
Eyenovia, Inc. Rebrands to Hyperion DeFi, Inc. and Announces Nasdaq Trading Under "HYPD" Ticker - Nasdaq
Eyenovia announces rebranding, name change to Hyperion DeFi - TipRanks
Eyenovia Rebrands to Hyperion DeFi, Focuses on Crypto - TipRanks
Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement - The Globe and Mail
Eyenovia Launches Co-Branded Hyperliquid Validator with Kinetiq - TipRanks
Eyenovia Shares Soar 56.78% on Crypto, CIO Hire - AInvest
Eyenovia Enters Blockchain Arena with Validator on Hyperliquid - CoinTrust
Eyenovia Climbs After-Hours On Revealing $50M Crypto Play And Validator Node Plans - MSN
Eyenovia launches validator node for Hyperliquid blockchain - Investing.com
Eyenovia Announces Co-Branded Validator with Kinetiq - GlobeNewswire
Eyenovia, Inc. Announces Board and Executive Changes - MarketScreener
Eyenovia Soars 12.23% on Crypto Rebranding - AInvest
Eyenovia Secures $50 Million for Cryptocurrency Treasury Reserve - AInvest
HYPE Token Drops 20% After Eyenovia and Lion Group Announcements - AInvest
Eyenovia Plunges 24.82% on HYPE Token Investment - AInvest
HYPE Price Drops Below $40 Despite $50M Eyenovia Investment - The Currency analytics
Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings - The Malaysian Reserve
Eyenovia Bets On Crypto Hype To Revive Struggling Stock - FinanceFeeds
Eyenovia (EYEN) Advances Digital Strategy with Key Developments - GuruFocus
Eyenovia Inc Stock (EYEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.32%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):